531739 GENNEX

Gennex Laboratories Share Price

 

 

Start SIP in GENNEX

Start SIP

Performance

  • Low
  • ₹14
  • High
  • ₹15
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹19
  • Open Price₹14
  • Previous Close₹14
  • Volume1,623,009

Investment Returns

  • Over 1 Month + 4.16%
  • Over 3 Month + 23.29%
  • Over 6 Month + 18.44%
  • Over 1 Year -13.83%

Smart Investing Starts Here Start SIP with Gennex Laboratories for Steady Growth!

Invest Now

Gennex Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.1
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 359
  • P/B Ratio
  • 1.7
  • Average True Range
  • 0.75
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.22
  • RSI
  • 64.34
  • MFI
  • 63.22

Gennex Laboratories Financials

Gennex Laboratories Technicals

EMA & SMA

Current Price
₹14.77
+ 0.47 (3.29%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹13.50
  • 50 Day
  • ₹13.59
  • 100 Day
  • ₹13.51
  • 200 Day
  • ₹13.75

Resistance and Support

14.42 Pivot Speed
  • R3 16.53
  • R2 15.71
  • R1 15.24
  • S1 13.95
  • S2 13.13
  • S3 12.66

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gennex Laboratories has an operating revenue of Rs. 151.75 Cr. on a trailing 12-month basis. An annual revenue growth of 62% is outstanding, Pre-tax margin of 16% is great, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 77 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 77 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Gennex Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-09-04 A.G.M.
2025-08-14 Quarterly Results
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Gennex Laboratories F&O

Gennex Laboratories Shareholding Pattern

23.62%
59.34%
17.04%

About Gennex Laboratories

  • NSE Symbol
  • GENNEX
  • BSE Symbol
  • 531739
  • Managing Director
  • Mr. Arihant Baid
  • ISIN
  • INE509C01026

Similar Stocks to Gennex Laboratories

Gennex Laboratories FAQs

Gennex Laboratories share price is ₹14 As on 02 January, 2026 | 07:32

The Market Cap of Gennex Laboratories is ₹358.8 Cr As on 02 January, 2026 | 07:32

The P/E ratio of Gennex Laboratories is 16.1 As on 02 January, 2026 | 07:32

The PB ratio of Gennex Laboratories is 1.7 As on 02 January, 2026 | 07:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23